Page last updated: 2024-09-03

l 158809 and Pancreatic Neoplasms

l 158809 has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chayama, K; Fujimoto, Y; Sasaki, T; Tsuchida, A	1

Other Studies

1 other study(ies) available for l 158809 and Pancreatic Neoplasms

Article	Year
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS letters, 2001, Apr-27, Volume: 495, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Cell Division; Dose-Response Relationship, Drug; Humans; Imidazoles; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transcription, Genetic; Tumor Cells, Cultured	2001

Article

Year

Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist.

FEBS letters, 2001, Apr-27, Volume: 495, Issue:3

Topics: Angiotensin II; Angiotensin Receptor Antagonists; Cell Division; Dose-Response Relationship, Drug; Humans; Imidazoles; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transcription, Genetic; Tumor Cells, Cultured

2001